Patents by Inventor Robert Tridgett

Robert Tridgett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 3,1IB-Cis-Dihydrotetrabenazine for the Treatment of Symptoms of Huntingtons Disease
    Publication number: 20080319000
    Abstract: The invention provides 3,11b-cis-dihydrotetrabenazine for use in halting or slowing the progress of one or more symptoms of Huntington's disease in a patient, and more particularly a symptom selected from involuntary movements such as involuntary chorea, tremors and twitches, and degeneration in gait.
    Type: Application
    Filed: July 13, 2006
    Publication date: December 25, 2008
    Applicant: CAMBRIDGE LABORATORIES (IRELAND) LIMITED
    Inventors: Robert Tridgett, Thierry Filloux
  • Dihydrotetrabenazines And Pharmaceutical Compositions Containing Them
    Publication number: 20080108645
    Abstract: The invention provides novel isomers of dihydrotetrabenazine, individual enantiomers and mixtures thereof wherein the dihydrotetrabenazine is a 3,11 b-cis-dihydrotetrabenazine. Also provided are methods for the preparation of the novel isomers, pharmaceutical compositions containing them and their use in treating hyperkinetic movement disorders such as Huntington's disease, hemiballismus, senile chorea, tic, tardive dyskinesia and Tourette's syndrome.
    Type: Application
    Filed: February 11, 2005
    Publication date: May 8, 2008
    Applicant: CAMBRIDGE LABORATORIES, (IRELAND), LTD.
    Inventors: Robert Tridgett, Ian Clarke, Robert Turtle, Grant Johnston